Compound 535
Identifiers
- Canonical SMILES:
Cc1cccc(C)c1C(=O)N[C@@H](Cc1c[nH]cn1)C(O)=O
- IUPAC name:
(2S)-2-[(2,6-dimethylbenzoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid
- InChi:
InChI=1S/C15H17N3O3/c1-9-4-3-5-10(2)13(9)14(19)18-12(15(20)21)6-11-7-16-8-17-11/h3-5,7-8,12H,6H2,1-2H3,(H,16,17)(H,18,19)(H,20,21)/t12-/m0/s1
- InChiKey:
RNMFDVJEHLKDQP-LBPRGKRZSA-N
External links
44305282 |
CHEMBL62991 |
23156188 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
LFA / ICAM | 5.75 | immune system disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 287.13 g/mol | |||
HBA | 6 | |||
HBD | 3 | |||
HBA + HBD | 9 | |||
AlogP | 0.42 | |||
TPSA | 95.08 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6917 | Carnosine | DB11695 | |
0.5769 | ORE-1001 | DB12271 | |
0.5556 | Prezatide | DB11296 | |
0.5517 | Palmitoyl oligopeptide | DB11297 | |
0.5467 | Ipamorelin | DB12370 | |
0.5398 | Histidine | DB00117 | |
0.5357 | 2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid | DB06922 | |
0.5298 | TRV-120027 | DB12199 | |
0.5294 | Enalkiren | DB03395 | |
0.5270 | Saralasin | DB06763 | |
0.5260 | Angiotensinamide | DB13517 | |
0.5252 | Cyclo(his-pro) | DB02414 | |
0.5177 | Protirelin | DB09421 | |
0.5172 | 2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID | DB07663 | |
0.5143 | Angiotensin II | DB11842 |